Evaluation of 177Lu-PSMA SPECT Quantitation as a Response Biomarker within a Prospective 177Lu-PSMA-617 and NOX66 Combination Trial (LuPIN).

Saved in:
Bibliographic Details
Title: Evaluation of 177Lu-PSMA SPECT Quantitation as a Response Biomarker within a Prospective 177Lu-PSMA-617 and NOX66 Combination Trial (LuPIN).
Authors: Pathmanandavel, Sarennya1, Crumbaker, Megan2,3,4, Ho, Bao1, Yam, Andrew O.2,3,4, Wilson, Peter5, Niman, Remy5, Ayers, Maria1, Sharma, Shikha1, Hickey, Adam1, Eu, Peter6, Stockler, Martin7, Martin, Andrew J.7, Joshua, Anthony M.2,3,4, Nguyen, Andrew1,4, Emmett, Louise1,3,4 louise.emmett@svha.org.au
Source: Journal of Nuclear Medicine. Oct2022, Vol. 63 Issue 10, p1-27. 27p.
Database: Engineering Source
Description
ISSN:01615505
DOI:10.2967/jnumed.122.264398